Phillip Scheinberg, MD, PhD, Highlights MDS at SOHO 2022
By Leah Sherwood - Last Updated: November 15, 2022Phillip Scheinberg, MD, PhD, highlights myelodysplastic syndromes (MDS) in this video from the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting.
Advertisement
Post Tags:MDS at SOHO 2022
Advertisement
Related Posts
The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.
The investigational small molecule enzomenib has received FDA Orphan Drug and Fast Track designations in AML.
The award provides early-career researchers at NCCN Member Institutions with $150,000 in funding to support cancer research.
More than 240 meetings were held with members of Congress as part of the ASCO 10th Annual Advocacy Summit.
This agent which has newly received an ODD for MDS recalibrates the immune system to attack hematological and solid tumors.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.